We are live on ! Find out more
OPXAW

Opexa Therapeutics, Inc.
OPXAW

Delisted

OPXAW was delisted on the 20th of September, 2017.

Back to rankings

5 hedge funds and large institutions have $176K invested in Opexa Therapeutics, Inc. in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

267% more capital invested

Capital invested by funds: $48K → $176K (+$128K)

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

25% more funds holding

Funds holding: 4 → 5 (+1)

Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
EEG
E.E. Geduld
+$5.51K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.7K
3
UBS Group
UBS Group
Switzerland
+$619

Top Sellers

Rank Fund Capital Flow
1
VKH
Virtu KCG Holdings
New York
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
1
Millennium Management
New York
$142K – – –
California Public Employees Retirement System
2
California Public Employees Retirement System
California
$25K – – –
EEG
3
E.E. Geduld
$6K +$5.51K +60,200 New
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$2K +$1.7K +18,596 New
UBS Group
5
UBS Group
Switzerland
$1K +$619 +6,757 +1,673%
VKH
6
Virtu KCG Holdings
New York
– -$1K -36,792 Closed

OPXAW Hedge Fund Activity: Q3 2016 in Review

5 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Opexa Therapeutics, Inc. (OPXAW) for Q3 2016, worth a combined $176K — up 267% from $48K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new OPXAW positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.

The largest buyer was E.E. Geduld, opening a new position worth an estimated $5.51K. The largest seller was Virtu KCG Holdings, exiting entirely with an estimated $1K sold.

  • 5 institutional investors held Opexa Therapeutics, Inc. (OPXAW) as of Q3 2016, up from 4 in Q2 2016.
  • Funds reported $176K of Opexa Therapeutics, Inc. stock for Q3 2016, up 267% quarter-over-quarter.
  • 2 funds opened new Opexa Therapeutics, Inc. positions in Q3 2016 and 1 closed out, a net change of +1 holder.
  • The largest Opexa Therapeutics, Inc. buyer in Q3 2016 was E.E. Geduld, an estimated $5.51K added.
  • The largest Opexa Therapeutics, Inc. seller in Q3 2016 was Virtu KCG Holdings, an estimated $1K sold.

Based on aggregated 13F filings for Q3 2016.